Orexigen Therapeutics Inc. said Jason Keyes resigned as executive vice president and CFO, effective Feb. 23, to pursue another business opportunity.
Keyes had been CFO since June 2016.
The La Jolla, Calif.-based company also appointed Monica Forbes as vice president and acting CFO, effective Feb. 24. Forbes joined Orexigen in October 2014 as senior director of financial planning and analysis.
Orexigen develops pharmaceutical products primarily in the U.S., Europe and South Korea.
